Methyl 2-(4-bromophenyl)-2-oxoacetate

Catalog No. :
ACRPEI490
CAS No. :
57699-28-2
Molecular Formula :
C9H7BrO3
Molecular Weight :
243.06

IUPAC Name:methyl 2-(4-bromophenyl)-2-oxoacetate

Methyl 2-(4-bromophenyl)-2-oxoacetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$61.00Login to see priceIn stockIn stock
5g97%$300.00Login to see priceIn stockIn stock
25g97%$1200.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(4-bromophenyl)-2-oxoacetate
IUPAC Namemethyl 2-(4-bromophenyl)-2-oxoacetate
MDL No.MFCD00193630
Molecular FormulaC9H7BrO3
Molecular Weight243.06
SMILESO=C(OC)C(C1=CC=C(Br)C=C1)=O
InChI KeyZFPFIURFXDPBIP-UHFFFAOYSA-N
Synonymmethyl 2-(4-bromophenyl)-2-oxoacetate | 57699-28-2 | methyl (4-bromophenyl)(oxo)acetate | 4-Bromo-oxo-benzeneacetic acid methyl ester | Methyl p-bromobenzoylformate | SCHEMBL7620437 | DTXSID80459133 | ZFPFIURFXDPBIP-UHFFFAOYSA-N | AMY10025 | MFCD00193630 | AKOS022176250 | meth
CAS No.57699-28-2
PubChem CID11218741

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H317-H319-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACRPEI490 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNLVD902 route compound structure diagram
    ACNLVD902127709-20-0 In Stock
  2. Then
  3. ACRPEI490 route product structure diagram
    ACRPEI49057699-28-2 In Stock
Inquiry

2. ACRPEI490 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNLVD902 route compound structure diagram
    ACNLVD902127709-20-0 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACRPEI490 route product structure diagram
    ACRPEI49057699-28-2 In Stock
Inquiry

Comments (0)